Tobacco use
Tobacco use has been studied in 151 papers since 2009: 108 observational studies in people, 23 reviews; 87 in the past year. The newest paper, Nov 16, 2026: “Risk-based stratification for genetic and modifiable factors in non-communicable diseases prevention: a scoping review of current guidance”.
Research on it is growing 6% slower than aging research as a whole: 18 papers in the latest year counted
23 new papers in 30 daysSee all 150 papers on tobacco use
At a glance
Human observational studies link tobacco use with multimorbidity, hypertension and worse cognition; independent labs report these associations again. Other studies associate it with higher mortality, while a preprint links at least five years of use with lower Parkinson's disease risk. The papers include company affiliations and declared company ties.
66 findings in 60 papers from 2009 to 2026, 23 of them since April 2026
Independent labs found the same change in people. 49 independent labs in 19 countries.
“the overall trend remained significantly increasing (AAPC, 9.38%; 95% CI, 7.17–11.65).”
None of its findings points the other way.
- 49 independent labs in 19 countries
- Funders: National Institutes of Health and others
- 4 of 60 findings with company ties
- Humans107
- In silico18
What did studies of tobacco use find?
8Studies of tobacco use measured 8 outcomes, among them ischemic heart disease mortality, biological age and gastrointestinal cancer.
Ischemic heart disease mortality
upin humans1
1 study
Ischemic heart disease mortality
upin humans1
Tobacco use is linked with higher ischemic heart disease mortality in humans (documented tobacco use) (AAMR rose from 3.90 to 32.37 (AAPC: 10.71; p < 0.01)).
“The AAMR rose from 3.90 to 32.37 (AAPC: 10.71; p < 0.01).”
Humansdocumented tobacco use1999-2023
Archives of public health = Archives belges de sante publique
Biological age
upin reviews1
1 study
Biological age
upin reviews1
Tobacco use increases biological age.
“Tobacco is a well-established accelerator of biological aging through adverse epigenetic reprogramming”
Review
Tobacco, biological aging and epigenetic resilience: the Andorran paradox
Frontiers in aging
Gastrointestinal cancer
no changein humans1
1 study
Gastrointestinal cancer
no changein humans1
Tobacco use was not clearly linked with gastrointestinal cancer in humans (Two-sample Mendelian randomization found no genetic evidence supporting an association).
“MR analysis did not provide genetic evidence supporting an association between tobacco use and these cancers.”
HumansTwo-sample Mendelian randomization found no genetic evidence supporting an association
Tobacco induced diseases
Disability-adjusted life years
upin humans1
1 study
Disability-adjusted life years
upin humans1
Tobacco use is linked with higher disability-adjusted life years in humans.
“The primary risk factors contributing to DALYs were high systolic blood pressure, air pollution, and tobacco use.”
Humans
BMC geriatrics
Biological age
upin humans1
1 study
Biological age
upin humans1
Tobacco use is linked with higher biological age in humans.
“evidence of tobacco and alcohol use and use disorders causally impacting physical, cognitive, and biological aging”
Humans
Examining the causal genetic effects of substance use on aging
medRxiv : the preprint server for health sciencesPreprint
Cognitive function
downin humans1
1 study
Cognitive function
downin humans1
Tobacco use is linked with worse cognitive function in humans.
“evidence of tobacco and alcohol use and use disorders causally impacting physical, cognitive, and biological aging”
Humans
Examining the causal genetic effects of substance use on aging
medRxiv : the preprint server for health sciencesPreprint
Physical function
downin humans1
1 study
Physical function
downin humans1
Tobacco use is linked with worse physical function in humans.
“evidence of tobacco and alcohol use and use disorders causally impacting physical, cognitive, and biological aging”
Humans
Examining the causal genetic effects of substance use on aging
medRxiv : the preprint server for health sciencesPreprint
Lung aging
upin humans1
1 study
Lung aging
upin humans1
Tobacco use increases lung aging in humans.
“Tobacco use accelerates lung aging and touches biological, structural and respiratory and non-respiratory functions.”
Review
Aging, tobacco use and lung damages
La Tunisie medicale
What is tobacco use linked with?
50Studies link tobacco use with 50 measures, most often multimorbidity (5 studies), hypertension (3) and mortality (2).
Multimorbidity
upin humans5OR 3.296
5 studies
Multimorbidity
upin humans5OR 3.296
Tobacco use is associated with multimorbidity in humans (Multivariable logistic regression among university employees in India) (Adjusted OR 3.296, 95% CI 1.377 to 7.888).
“tobacco use (aOR 3.296, 95% CI 1.377 to 7.888) were independently associated with multimorbidity.”
HumansMultivariable logistic regression among university employees in Indian = 266
medRxivPreprint
Tobacco use is associated with multimorbidity in humans (adjusted for age, sex, and household socioeconomic status) (aOR 1.23 (95% CI 1.01-1.50)).
“Current tobacco consumption (adjusted odds ratio (aOR) = 1.23 [95% confidence interval (CI): 1.01-1.50]), physical inactivity (aOR: 1.66 [95% CI: 1.38-1.99]), and poor sleep”
Humansadjusted for age, sex, and household socioeconomic statusn = 5,332
PLOS global public health
Tobacco use is associated with multimorbidity in humans (higher odds of multimorbidity).
“older age, male sex, and tobacco and alcohol use were significantly associated with higher odds of multimorbidity”
Humans
Global epidemiology
Tobacco use is associated with multimorbidity in humans (former tobacco users in Indonesia).
“Being obese, overweight and a former tobacco user was associated with a higher number of chronic conditions and multimorbidity (p < 0.05).”
Humansformer tobacco users in Indonesian = 12,081
BMC health services research
Tobacco use is associated with multimorbidity in humans (Women in India).
“women who were consuming tobacco as compared to their counterparts.”
HumansWomen in Indiafemales
International journal of public health
Hypertension
upin humans3
3 studies
Hypertension
upin humans3
Tobacco use predicts hypertension in humans (patients admitted to Kamenge Teaching Hospital).
“Predictors of hypertension included age ≥ 40 years, tobacco use, education level, and excess weight.”
Humanspatients admitted to Kamenge Teaching Hospitaln = 714
Research SquarePreprint
Tobacco use is associated with hypertension in humans.
“Hypertension is associated to factors such as increasing age, BMI, physical inactivity, tobacco use, and diabetes.”
Humans
Journal of racial and ethnic health disparities
Tobacco use is linked with a higher risk of hypertension in humans (AOR = 1.33, CI = 1.05-1.70).
“Other factors that were significantly associated with being hypertensive included tobacco use (AOR = 1.33, CI = 1.05-1.70)”
Humans
Annals of work exposures and health
Mortality
upin humans2
2 studies
Mortality
upin humans2
Tobacco use is linked with a higher risk of mortality in humans (2.38 million (95% UI 2.02-2.83) deaths).
“In 2023, tobacco use caused 2.38 million [95% uncertainty interval (UI) 2.02-2.83] deaths and 57.27 million (95% UI 48.28-60.82) DALYs, predominantly premature mortality”
Humans
Military Medical Research
Tobacco use is associated with mortality in humans (deaths due to dementia) (from 3.25 in 2005 to 12.87 in 2020 per 100,000).
“The AAMR observed a significantly steep incline from 3.25 in 2005 to 12.87 in 2020.”
Humansdeaths due to dementia2005-2020n = 63,623
Neurodegenerative disease management
Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
Tobacco use is associated with cardiovascular disease in humans (Studies in Nepal).
“Tobacco use was associated with cardiovascular diseases, chronic respiratory diseases, and oral cancer.”
ReviewStudies in Nepal
Determinants of risk factors for Non-Communicable Diseases (NCDs) in Nepal: a scoping review
BMC public health
Suspected oral potentially malignant disorders
upin humans1
1 study
Suspected oral potentially malignant disorders
upin humans1
Tobacco use is associated with suspected oral potentially malignant disorders in humans (Permanent residents of Villianur Commune, Puducherry).
“Tobacco use, poor oral hygiene, and low socioeconomic status were significant risk factors.”
HumansPermanent residents of Villianur Commune, Puducherryn = 196
Research SquarePreprint
Ischemic heart disease burden
upin humans1
1 study
Ischemic heart disease burden
upin humans1
Tobacco use is associated with ischemic heart disease burden in humans (Central Europe).
“tobacco use disproportionately affected men.”
HumansCentral Europemale versus females
ESC Congress 2026 abstract
FC-mediated Alzheimer's disease risk
mixedin silico1
1 study
FC-mediated Alzheimer's disease risk
mixedin silico1
Tobacco use is associated with FC-mediated Alzheimer's disease risk in silico (estimated using InterventionVAE).
“We also identify earlier-life modifiable factors including tobacco use, sleep quality, physical activity, and weight/BMI that significantly influence AD risk.”
In silicoestimated using InterventionVAEbrain
Imaging neuroscience (Cambridge, Mass.)
Newly diagnosed hypertension
upin humans1
1 study
Newly diagnosed hypertension
upin humans1
Tobacco use predicts newly diagnosed hypertension in humans (Patients admitted at Kamenge Teaching Hospital in Burundi).
“Significant predictors included age ≥ 40, tobacco use, higher education, and excess weight.”
HumansPatients admitted at Kamenge Teaching Hospital in Burundin = 714
Research SquarePreprint
Ischemic heart disease mortality
upin humans1
1 study
Ischemic heart disease mortality
upin humans1
Tobacco use is associated with ischemic heart disease mortality in humans (AAPC, 9.38%; 95% CI, 7.17–11.65).
“the overall trend remained significantly increasing (AAPC, 9.38%; 95% CI, 7.17–11.65).”
Humans1999–2024
Research SquarePreprint
Chronic obstructive pulmonary disease
upin humans1
1 study
Chronic obstructive pulmonary disease
upin humans1
Tobacco use raises the risk of chronic obstructive pulmonary disease in humans.
“Tobacco use is the single largest preventable risk factor for Chronic Obstructive Pulmonary Disease (COPD) in Australia.”
Review
Theoretical and Natural Science
All 50Fewer
What acts on tobacco use?
1Studies name High-tobacco-burden states as acting on tobacco use.
High-tobacco-burden states
upin humans1
1 study
High-tobacco-burden states
upin humans1
high-tobacco-burden states are linked with higher tobacco use in humans (high- vs lower-tobacco-burden states) (35.3% vs 28.3%).
“The prevalence of tobacco use was higher in high-tobacco-burden states than in lower-tobacco-burden states overall (35.3% vs 28.3%)”
Humanshigh- vs lower-tobacco-burden statesn = 12,300
American journal of preventive medicine
Funding
16 grants since 2018National Cancer Institute$9.7MNational Institute on Drug Abuse$2.6MNational Institute for Health Research£2.7M
National Cancer InstituteRutgers Biomedical and Health Sciences$1.4M2026–2031
National Cancer InstituteH. Lee Moffitt Cancer Ctr & Res Inst$154K2021–2027
National Cancer InstituteUniversity of Nebraska Medical Center$179K2026–2028
National Cancer InstituteGeorge Washington University$481K2023–2027
National Institute on Drug AbuseMedical University of South Carolina$733K2023–2028
National Cancer InstituteBrown University$606K2024–2028
Electronic Pediatric Office Systems to Support Treatment for Parental Tobacco Use
National Cancer InstituteMassachusetts General Hospital$900K2020–2025
National Cancer InstituteUniversity of Michigan at Ann Arbor$339K2022–2025
National Institute on Drug AbuseUniversity of California Los Angeles$249K2018–2024
National Cancer InstituteNew York University School of Medicine$206K2021–2023
How this record changed
Summary written from the findings.